FOSCAN

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Netherlands, Poland, UK.

Active ingredients

The drug FOSCAN contains one active pharmaceutical ingredient (API):

1	Temoporfin UNII FU21S769PF - TEMOPORFIN
	Temoporfin is a photosensitising agent used in the photodynamic therapy of tumours.
	Read more about Temoporfin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FOSCAN Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01XD05	Temoporfin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XD Sensitizers used in photodynamic/radiation therapy
Discover more medicines within L01XD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1208438, 1208449, 1364251, 1364262, 1364273
FR	Base de données publique des médicaments	61430956, 67009330
GB	Medicines & Healthcare Products Regulatory Agency	215583, 215586
IT	Agenzia del Farmaco	036433011, 036433023, 036433035, 036433047, 036433050
LT	Valstybinė vaistų kontrolės tarnyba	1028598, 1028599, 1028600, 1028601, 1028602
NL	Z-Index G-Standaard, PRK	138290, 138304
PL	Rejestru Produktów Leczniczych	100244390